Perbedaan Organon Pharma Indonesia Tbk. dan Tunas Alfin Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tunas Alfin Tbk. diperdagangkan di Rp710 (kapitalisasi pasar 927,1 M, volume 24 jam 392,7 rb). Perbedaan utamanya: Tunas Alfin Tbk. jauh lebih besar — sekitar 8,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TALF | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 927,1 M |
Volume | — | 392,7 rb |
Lot | — | 3,93 rb |
Perputaran | — | 279,69 jt |
Harga Rata-rata | — | 712,23 |
Nilai Transaksi | — | 279,69 jt |
Harga Ekuilibrium Indikatif | — | 710 |
Volume Ekuilibrium Indikatif | — | 5 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.
Selengkapnya di halaman TALF →